Angelo Scopelianos, Ph.D.

Angelo Scopelianos, Ph.D.

Chief Research and Development OfficeratAxogen· In proxies 2021–2023

Pay in FY2023Axogen stock -31.6% the same year

Angelo Scopelianos, Ph.D. was paid $1.8M in FY2023 (Dec). Axogen stock fell 31.6% that year.

Pay$100 in the stock at the end of FY20 → $36
Pay is from the Summary Compensation Table of each Axogen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AxogenPublic company · 5 yr
    • Chief Research and Development Officer2021 – Present · 5 yrStock in role +178%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?